Scott explains how antibody medicines work by infusing pre-made antibodies into patients, effectively providing them with an intact immune response. He highlights the challenges of scaling production during a crisis and discusses the potential of antiviral pills, likening them to Tamiflu for influenza. With promising developments from various companies, he remains optimistic about finding effective treatments for COVID-19.
